Merck KGaA Licenses Niaspan and Advicor from Kos
By Business Review Editor
Pharma Deals Review: Vol 2002 Issue 30 (Table of Contents)
Published: 2 Nov-2002
DOI: 10.3833/pdr.v2002.i30.978 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
Merck KGaA entered into licensing agreement with Kos Pharmaceuticals for Niaspan® and Advicor™ for the treatment of hyperlipidemia...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS